Viveve Medical, Inc.
VIVE
$0.00
$0.0050.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -12.39% | -30.22% | -3.39% | -0.51% | -- |
| Total Depreciation and Amortization | -34.36% | -32.15% | -21.74% | -12.18% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.02% | 72.60% | -39.32% | -33.79% | -- |
| Change in Net Operating Assets | -79.55% | 8.23% | 126.05% | 928.17% | -- |
| Cash from Operations | -35.84% | -29.19% | -15.38% | 15.47% | -- |
| Capital Expenditure | -10.19% | 14.29% | 40.43% | 41.61% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.19% | 14.29% | 40.43% | 41.61% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.74% | -99.76% | -97.65% | 197.70% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 101.39% | 100.83% | 96.56% | 91.87% | -- |
| Cash from Financing | -99.73% | -99.76% | -97.78% | 181.40% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.46% | -194.49% | -174.22% | 286.28% | -- |